| 1 | Surgical and endoscopic management of clinical T1b esophageal cancer | 2.6 | 3 | Citations (PDF) |
| 2 | Recent Survival Gains in Stage IV NSCLC by Sociodemographic Strata | 0.9 | 0 | Citations (PDF) |
| 3 | Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation | 2.3 | 7 | Citations (PDF) |
| 4 | Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgery | 2.6 | 10 | Citations (PDF) |
| 5 | Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy | 2.3 | 8 | Citations (PDF) |
| 6 | Medicaid Expansion Under the Affordable Care Act and Early Mortality Following Lung Cancer Surgery | 6.6 | 16 | Citations (PDF) |
| 7 | Survival Among Patients With High-Risk Gastrointestinal Cancers During the COVID-19 Pandemic | 6.6 | 11 | Citations (PDF) |
| 8 | Renovating the Commission on Cancer’s Quality Measure Portfolio | 4.6 | 2 | Citations (PDF) |
| 9 | Salvage lung resection after immunotherapy is feasible and safe | 1.2 | 8 | Citations (PDF) |
| 10 | Association of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer | 2.6 | 5 | Citations (PDF) |
| 11 | American College of Surgeons Operative Standards and Breast Cancer Outcomes | 6.6 | 10 | Citations (PDF) |
| 12 | Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non–Small Cell Lung Cancer | 2.3 | 12 | Citations (PDF) |
| 13 | Off-Pump Methacrylate Cement Pulmonary Embolectomy | 0.2 | 0 | Citations (PDF) |
| 14 | Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification Reform | 2.3 | 6 | Citations (PDF) |
| 15 | Disruption of National Cancer Database Data Models in the First Year of the COVID-19 Pandemic | 8.8 | 32 | Citations (PDF) |
| 16 | Association of Wildfire Exposure While Recovering From Lung Cancer Surgery With Overall Survival | 14.3 | 33 | Citations (PDF) |
| 17 | Assessment of a collaborative treatment model for trimodal management of esophageal cancer | 1.2 | 2 | Citations (PDF) |
| 18 | National Cancer Database Reports Ongoing Disruptions in Cancer Diagnoses in 2021 | 2.3 | 2 | Citations (PDF) |
| 19 | Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US | 6.6 | 18 | Citations (PDF) |
| 20 | Role of adjuvant therapy in T1-2N0 resected non–small cell lung cancer | 2.6 | 5 | Citations (PDF) |
| 21 | Understanding the Implications of Medicaid Expansion for Cancer Care in the US | 14.3 | 39 | Citations (PDF) |
| 22 | Access to High-Volume Hospitals for High-Risk Cancer Surgery for Racial and Ethnic Minoritized Groups | 2.9 | 5 | Citations (PDF) |
| 23 | Nonadherence to Multimodality Cancer Treatment Guidelines in the United States | 1.3 | 8 | Citations (PDF) |
| 24 | Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications | 1.2 | 0 | Citations (PDF) |
| 25 | Appendiceal Cancer in the National Cancer Database: Increasing Frequency, Decreasing Age, and Shifting Histology | 0.7 | 30 | Citations (PDF) |
| 26 | Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer | 6.6 | 4 | Citations (PDF) |
| 27 | Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US | 6.6 | 32 | Citations (PDF) |
| 28 | Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer Diagnosis | 6.6 | 55 | Citations (PDF) |
| 29 | Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer | 0.9 | 5 | Citations (PDF) |
| 30 | Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer | 0.9 | 2 | Citations (PDF) |
| 31 | Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database | 2.3 | 29 | Citations (PDF) |
| 32 | Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study | 1.2 | 2 | Citations (PDF) |
| 33 | The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases | 0.9 | 4 | Citations (PDF) |
| 34 | Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules | 2.3 | 3 | Citations (PDF) |
| 35 | Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data | 2.3 | 14 | Citations (PDF) |
| 36 | Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis | 1.2 | 8 | Citations (PDF) |
| 37 | Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation | 6.6 | 31 | Citations (PDF) |
| 38 | Consensus for Thoracoscopic Left Upper Lobectomy—Essential Components and Targets for Simulation | 2.3 | 13 | Citations (PDF) |
| 39 | Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting? | 0.9 | 2 | Citations (PDF) |
| 40 | Baseline Evaluation of Cancer Mortality in US States that Expanded Medicaid vs Nonexpansion States | 14.3 | 2 | Citations (PDF) |
| 41 | A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors | 2.3 | 16 | Citations (PDF) |
| 42 | Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort? | 2.3 | 4 | Citations (PDF) |
| 43 | Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma | 2.3 | 17 | Citations (PDF) |
| 44 | Sternotomy for aortic dissection with substernal pull through: The importance of surgical history | 2.6 | 4 | Citations (PDF) |
| 45 | Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer Surgery | 2.9 | 7 | Citations (PDF) |
| 46 | Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction | 2.3 | 4 | Citations (PDF) |
| 47 | Surgeon's Perspective to Local Therapy in Oligometastatic Cancer | 1.8 | 2 | Citations (PDF) |
| 48 | Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features | 14.3 | 84 | Citations (PDF) |
| 49 | Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act | 6.6 | 4 | Citations (PDF) |
| 50 | Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer | 2.3 | 13 | Citations (PDF) |
| 51 | Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway | 2.3 | 14 | Citations (PDF) |
| 52 | Association of Programmed Cell Death Ligand 1 Expression Status With Receipt of Immune Checkpoint Inhibitors in Patients With Advanced Non–Small Cell Lung Cancer | 6.6 | 26 | Citations (PDF) |
| 53 | Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals | 6.6 | 40 | Citations (PDF) |
| 54 | Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer | 2.3 | 51 | Citations (PDF) |
| 55 | Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database | 2.3 | 6 | Citations (PDF) |
| 56 | Where the Other Half Dies: Analysis of Mortalities Occurring More Than 30 Days After Complex Cancer Surgery | 2.3 | 20 | Citations (PDF) |
| 57 | Quality Versus Quantity | 4.6 | 21 | Citations (PDF) |
| 58 | Defining the learning curve in robot-assisted thoracoscopic lobectomy | 1.8 | 40 | Citations (PDF) |
| 59 | Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer | 6.6 | 43 | Citations (PDF) |
| 60 | Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma 2019, 7, | | 72 | Citations (PDF) |
| 61 | Variations in Surgical Safety According to Affiliation Status With a Top-Ranked Cancer Hospital | 14.3 | 3 | Citations (PDF) |
| 62 | Regionalization of esophagectomy: where are we now? | 1.2 | 25 | Citations (PDF) |
| 63 | Identifying Drivers of Multiple Readmissions After Pulmonary Lobectomy | 2.3 | 9 | Citations (PDF) |
| 64 | Lack of correlation between short- and long-term performance after lung cancer surgery | 2.6 | 17 | Citations (PDF) |
| 65 | Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancer | 1.2 | 11 | Citations (PDF) |
| 66 | Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer Surgery | 6.6 | 39 | Citations (PDF) |
| 67 | Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery? | 0.7 | 0 | Citations (PDF) |
| 68 | The Society of Thoracic Surgeons General Thoracic Surgery Database: 2019 Update on Research | 2.3 | 6 | Citations (PDF) |
| 69 | Single-cell connectomic analysis of adult mammalian lungs | 10.9 | 231 | Citations (PDF) |
| 70 | Variable impact of prior cancer history on the survival of lung cancer patients | 2.6 | 13 | Citations (PDF) |
| 71 | Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons General Thoracic Surgery Database for Lobectomy | 2.3 | 35 | Citations (PDF) |
| 72 | Timing and Risk Factors Associated With Venous Thromboembolism After Lung Cancer Resection | 2.3 | 46 | Citations (PDF) |
| 73 | Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA | 6.8 | 407 | Citations (PDF) |
| 74 | Primary Salivary Type Lung Cancers in the National Cancer Database | 2.3 | 25 | Citations (PDF) |
| 75 | Robotic-Assisted Lobectomies in the National Cancer Database | 0.7 | 25 | Citations (PDF) |
| 76 | Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database | 2.3 | 60 | Citations (PDF) |
| 77 | Differential effects of operative complications on survival after surgery for primary lung cancer | 2.6 | 64 | Citations (PDF) |
| 78 | Local Option: The Rational Use of Local Therapy in Patients at High Risk to Die of Metastatic Progression | 2.9 | 5 | Citations (PDF) |
| 79 | Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma | 1.4 | 2 | Citations (PDF) |
| 80 | Distinctive features of gastrointestinal stromal tumors arising from the colon and rectum | 1.4 | 13 | Citations (PDF) |
| 81 | Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer Database | 1.2 | 11 | Citations (PDF) |
| 82 | Video-assisted thoracoscopic surgery lobectomy: transitions in practice | 1.2 | 1 | Citations (PDF) |
| 83 | Motivators, Barriers, and Facilitators to Traveling to the Safest Hospitals in the United States for Complex Cancer Surgery | 6.6 | 95 | Citations (PDF) |
| 84 | US Public Perceptions About Cancer Care Provided by Smaller Hospitals Associated With Large Hospitals Recognized for Specializing in Cancer Care | 14.3 | 15 | Citations (PDF) |
| 85 | When good operations go bad: The additive effect of comorbidity and postoperative complications on readmission after pulmonary lobectomy | 1.8 | 9 | Citations (PDF) |
| 86 | Invited Commentary | 0.7 | 0 | Citations (PDF) |
| 87 | Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy | 1.8 | 4 | Citations (PDF) |
| 88 | Why Travel for Complex Cancer Surgery? Americans React to ‘Brand-Sharing’ Between Specialty Cancer Hospitals and Their Affiliates | 2.3 | 21 | Citations (PDF) |
| 89 | Using the National Cancer Database for Outcomes Research | 14.3 | 1,041 | Citations (PDF) |
| 90 | Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT | 2.6 | 80 | Citations (PDF) |
| 91 | Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival | 1.1 | 67 | Citations (PDF) |
| 92 | Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery | 2.6 | 29 | Citations (PDF) |
| 93 | Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection | 2.3 | 44 | Citations (PDF) |
| 94 | Surgically Managed Clinical Stage IIIA–Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database | 2.3 | 44 | Citations (PDF) |
| 95 | Length of Stay From the Hospital Perspective | 4.6 | 45 | Citations (PDF) |
| 96 | Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall | 2.8 | 15 | Citations (PDF) |
| 97 | Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery | 14.3 | 173 | Citations (PDF) |
| 98 | Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenarians | 1.8 | 13 | Citations (PDF) |
| 99 | Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System | 2.3 | 12 | Citations (PDF) |
| 100 | The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies | 1.4 | 34 | Citations (PDF) |
| 101 | The Eighth Edition Lung Cancer Stage ClassificationChest, 2017, 151, 193-203 | 1.0 | 1,518 | Citations (PDF) |
| 102 | Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer | 2.1 | 61 | Citations (PDF) |
| 103 | Hospital Volume and Outcomes of Robot-Assisted LobectomiesChest, 2017, 151, 329-339 | 1.0 | 53 | Citations (PDF) |
| 104 | Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer | 2.3 | 35 | Citations (PDF) |
| 105 | It’s All in the “Swerve of the Curve” | 2.1 | 0 | Citations (PDF) |
| 106 | Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database | 0.7 | 38 | Citations (PDF) |
| 107 | The Natural History of Operable Non-Small Cell Lung Cancer in the National Cancer Database | 2.3 | 65 | Citations (PDF) |
| 108 | Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base | 2.1 | 107 | Citations (PDF) |
| 109 | Longitudinal Follow-up of Lung Cancer Resection From the Society of Thoracic Surgeons General Thoracic Surgery Database in Patients 65 Years and Older | 2.3 | 37 | Citations (PDF) |
| 110 | Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer | 2.6 | 113 | Citations (PDF) |
| 111 | Estimating the Annual Incremental Cost of Several Complications Following Pulmonary Lobectomy | 1.6 | 11 | Citations (PDF) |
| 112 | A model for predicting prolonged length of stay in patients undergoing anatomical lung resection: a National Surgical Quality Improvement Program (NSQIP) database study | 1.4 | 16 | Citations (PDF) |
| 113 | Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe | 2.1 | 25 | Citations (PDF) |
| 114 | Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase | 1.4 | 2 | Citations (PDF) |
| 115 | Resection of oligometastatic lung cancer to the pancreas may yield a survival benefit in select patients – A systematic review | 0.7 | 18 | Citations (PDF) |
| 116 | Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database | 2.3 | 43 | Citations (PDF) |
| 117 | Hospital Readmission After Pulmonary Lobectomy Is Not Affected by Surgical Approach | 2.3 | 38 | Citations (PDF) |
| 118 | Impact of Adjuvant Treatment for Microscopic Residual Disease After Non-Small Cell Lung Cancer Surgery | 2.3 | 75 | Citations (PDF) |
| 119 | The vats advantage: seeing is believing ... and vice versa | 2.6 | 2 | Citations (PDF) |
| 120 | Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base | 2.1 | 145 | Citations (PDF) |
| 121 | Cardiovascular Complications Following Thoracic Surgery | 1.4 | 18 | Citations (PDF) |
| 122 | Pleural Space Complications Associated with Lung Transplantation | 1.4 | 27 | Citations (PDF) |
| 123 | Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm | 2.3 | 10 | Citations (PDF) |
| 124 | Predictors of Mortality After Surgical Management of Lung Cancer in the National Cancer Database | 2.3 | 107 | Citations (PDF) |
| 125 | Learning Curve to Lymph Node Resection in Minimally Invasive Esophagectomy for Cancer | 0.9 | 15 | Citations (PDF) |
| 126 | Experience with Thoracoscopic Pneumonectomies at a Single Institution | 0.9 | 6 | Citations (PDF) |
| 127 | Minimally invasive oesophagectomy more expensive than open despite shorter length of stay | 1.4 | 23 | Citations (PDF) |
| 128 | Transcervical Wedge Resection after Transcervical Extended Mediastinal Lymphadenectomy | 0.9 | 3 | Citations (PDF) |
| 129 | Lethality of Cardiovascular Events Highlights the Variable Impact of Complication Type Between Thoracoscopic and Open Pulmonary Lobectomies | 2.3 | 19 | Citations (PDF) |
| 130 | Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer | 2.6 | 150 | Citations (PDF) |
| 131 | Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base | 2.3 | 9 | Citations (PDF) |
| 132 | Management of Clinical Stage IIIA Primary Lung Cancers in the National Cancer Database | 2.3 | 39 | Citations (PDF) |
| 133 | Impact of preoperative radiation on survival of patients with T3N0 >7-cm non–small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database | 1.6 | 8 | Citations (PDF) |
| 134 | Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival | 1.4 | 38 | Citations (PDF) |
| 135 | Endobronchial Treatment of Pulsatile Hemoptysis Complicating Y-Stent Management of Tracheobronchomalacia | 1.0 | 0 | Citations (PDF) |
| 136 | Self-perceived video-assisted thoracic surgery lobectomy proficiency by recent graduates of North American thoracic residencies | 1.4 | 29 | Citations (PDF) |
| 137 | Stereotactic Body Radiotherapy for Central Lung Tumors | 2.1 | 121 | Citations (PDF) |
| 138 | Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections | 2.3 | 280 | Citations (PDF) |
| 139 | Outcomes for Lung Transplantation for Lung Cancer in the United Network for Organ Sharing Registry | 2.3 | 49 | Citations (PDF) |
| 140 | Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer | 2.3 | 10 | Citations (PDF) |
| 141 | Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer Outcomes | 2.3 | 100 | Citations (PDF) |
| 142 | An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non–small cell lung cancer | 2.6 | 94 | Citations (PDF) |
| 143 | The Revised Stage Classification System for Primary Lung Cancer | 3.4 | 4 | Citations (PDF) |
| 144 | Long-term survival after lung resection for non–small cell lung cancer with circulatory bypass: A systematic review | 2.6 | 67 | Citations (PDF) |
| 145 | Invited Commentary | 2.3 | 0 | Citations (PDF) |
| 146 | Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer? | 2.1 | 34 | Citations (PDF) |
| 147 | Update on Cardiothoracic Surgery Resident Job Opportunities | 2.3 | 22 | Citations (PDF) |
| 148 | The New Lung Cancer Staging SystemChest, 2009, 136, 260-271 | 1.0 | 836 | Citations (PDF) |
| 149 | Pulmonary artery agenesis and Kommerell's diverticulum presenting with hemoptysis | 1.4 | 5 | Citations (PDF) |
| 150 | Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors | 2.6 | 492 | Citations (PDF) |
| 151 | Decortication After Lung Transplantation | 2.3 | 24 | Citations (PDF) |
| 152 | A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery☆☆☆ | 1.4 | 122 | Citations (PDF) |
| 153 | Current Surgical Opinion of Computed Tomography for Acute Appendicitis | 1.2 | 10 | Citations (PDF) |
| 154 | Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes | 2.5 | 38 | Citations (PDF) |
| 155 | Surgical techniques for nonseminomatous germ cell tumors metastatic to the lung | 1.4 | 10 | Citations (PDF) |
| 156 | Atheroemboli to Superior Mesenteric Artery following Cardiopulmonary Bypass | 1.1 | 8 | Citations (PDF) |
| 157 | Patient-reported health-related social needs obtained at the bedside and outcomes after elective major surgery | 1.8 | 6 | Citations (PDF) |
| 158 | Real-world perioperative outcomes of neoadjuvant chemoimmunotherapy in non–small cell lung cancer | 1.2 | 1 | Citations (PDF) |
| 159 | Response to neoadjuvant chemoimmunotherapy in EGFR- or ALK-mutated non-small cell lung cancer. | 16.9 | 0 | Citations (PDF) |
| 160 | Treatment and Prognosis of Thymic Neuroendocrine Neoplasms in the United States | 0.2 | 0 | Citations (PDF) |
